Columbia, MO, United States of America

Feng Qi

This inventor holds 1 USPTO granted patent. Top assignees: Nanova, Inc., University of Missouri. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Feng Qi. Retrieved from https://idiyas.com/inventor/feng-qi-9ph8d9vv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Feng Qi: Innovator in Bacterial Infection Treatment

Introduction

Feng Qi is a notable inventor based in Columbia, MO (US). He has made significant contributions to the field of medical research, particularly in the treatment of bacterial infections. His innovative work has led to the development of valuable therapeutic agents.

Latest Patents

Feng Qi holds 1 patent for his invention titled "Methods and compositions for treating bacterial infection." This patent focuses on chemical compounds and methods for their discovery, emphasizing their therapeutic and research applications. The disclosure highlights compounds that serve as therapeutic agents against bacterial infections, including biofilms. Additionally, it provides topical formulations designed for treating these infections.

Career Highlights

Throughout his career, Feng Qi has worked with esteemed organizations such as the University of Missouri and Nanova, Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Feng Qi has collaborated with notable colleagues, including Hongmin Sun and David W. Anderson. These partnerships have further enriched his research endeavors and expanded the impact of his work.

Conclusion

Feng Qi's innovative contributions to the treatment of bacterial infections demonstrate his commitment to advancing medical science. His patent and collaborations reflect his dedication to improving therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…